UroGen Pharma Ltd. (URGN) quarterly cash flow statement — complete operating, investing & financing history
UroGen Pharma Ltd. (URGN) cash flow statement — 13-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -33.01M | -45.32M | -38.33M | -42.27M | -39.83M | -42.02M | -13.62M | -27.66M | -23.75M | -31.73M | -13.06M | -17.3M | -20.27M | -25.81M | -20.49M | -16.7M | -23.11M | -24M | -20.07M | -18.48M |
| Operating CF Margin % | -45.55% | -88.93% | -101.29% | -153.81% | -164.46% | -207.48% | -55.44% | -109.76% | -108.7% | -168.97% | -55.49% | -82.96% | -95.91% | -150.11% | -113.28% | -103.75% | -139.19% | -176.91% | -124.09% | -162.77% |
| Operating CF Growth % | 17.12% | -7.83% | -181.41% | -52.8% | -67.7% | -32.42% | -4.31% | -59.92% | -17.14% | -22.97% | 36.3% | -3.59% | 12.28% | -7.55% | -2.11% | 9.61% | -21.99% | 12.43% | 5.52% | 26.33% |
| Net Income | -14.35M | -23.57M | -26.36M | -33.35M | -49.94M | -43.84M | -37.51M | -23.67M | -33.4M | -32.29M | -26.02M | -21.88M | -24.14M | -30.21M | -28.25M | -25.83M | -26.69M | -28.39M | -28.45M | -30.21M |
| Depreciation & Amortization | 668K | 652K | 679K | 639K | 596K | 497K | 306K | 266K | 263K | 351K | 424K | 415K | 431K | 435K | 450K | 435K | 476K | 456K | 451K | 452K |
| Stock-Based Compensation | 5.33M | 4.63M | 3.13M | 3.03M | 2.73M | 3.07M | 3.3M | 3.49M | 3.56M | 2.76M | 2.61M | 2.22M | 2.22M | 2.29M | 0 | 0 | 0 | 2.95M | 5.36M | 5.51M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.25M | 2.77M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -81K | 3.06M | 2.49M | 915K | 1.55M | 839K | 4.79M | 1.38M | 3.27M | 1.46M | 7.59M | 222K | 3.15M | 2.92M | 6.5M | 7.32M | 8.01M | 4.62M | 7.23M | 6.87M |
| Working Capital Changes | -24.57M | -30.08M | -18.26M | -13.5M | 5.24M | -2.59M | 15.49M | -9.12M | 2.57M | -4.01M | 6.58M | -1.05M | -1.95M | -1.24M | 803.16K | 1.37M | -4.9M | -3.63M | -4.65M | -1.1M |
| Change in Receivables | -33.34M | -22.33M | -14.18M | -54K | -11K | 664K | 2.5M | -5.39M | -3.26M | 1.28M | -2.5M | 2.66M | -3.01M | 211K | -3.17M | 2.1M | -2.1M | 2.22M | -3.93M | 1.73M |
| Change in Inventory | -3.67M | -4.46M | -8.6M | -1.21M | 462K | 1.64M | -1.63M | -152K | -199K | -1.57M | -645.04K | -14K | 477K | -1.14M | 276.87K | -156.23K | -545.17K | 76K | -1.02M | -387K |
| Change in Payables | 4.6M | 7.63M | 1.62M | -4.79M | 640K | 2.89M | 7.75M | -4.07M | 5.6M | 1.62M | 2.36M | -2.32M | -727K | 4.75M | 2.93M | 713.51K | -1.21M | -2.17M | 0 | 0 |
| Cash from Investing | 1.67M | -20.69M | 27.72M | 31.4M | 28.41M | -25.96M | 60.62M | -106.75M | 12M | 13.52M | -11.34M | 401K | 3.72M | 6.27M | 22.4M | -34.52M | -454.28K | 13.6M | 9.13M | 10.66M |
| Capital Expenditures | -60K | -54K | -17K | -87K | -141K | -44K | -115K | -96K | -84K | 0 | -53.54K | -100K | -15K | -23K | -10.87K | -147.66K | -61.01K | -25K | -202K | -194K |
| CapEx % of Revenue | 0.08% | 0.11% | 0.04% | 0.32% | 0.58% | 0.22% | 0.47% | 0.38% | 0.38% | - | 0.23% | 0.48% | 0.07% | 0.13% | 0.06% | 0.92% | 0.37% | 0.18% | 1.25% | 1.71% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.29M | -501K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -60.03M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11.65M | 501K | 0 | 0 | 0 | 0 | 0 | 0 | 9.33M | 10.85M |
| Cash from Financing | 500K | 65.2M | 31.32M | 8.27M | 296K | 34K | 71K | 39.61M | 100.28M | 54.66M | 40K | 116.08M | 143K | 671K | 23.94M | 514.87K | -1.67M | 70.74M | -32K | -168K |
| Debt Issued (Net) | 64.96M | -321K | -1.97M | 0 | 0 | 0 | -24.39M | 24.39M | 0 | 0 | 0 | 0 | 0 | 0 | 23.58M | -553.69K | -1.63M | 70.83M | 0 | 0 |
| Equity Issued (Net) | 887K | 179K | -34K | 8.27M | 296K | 34K | -151.17M | 15M | 81.51M | 54.66M | -377.96K | 67.36M | 0 | 0 | 357.31K | 1.07M | -36.11K | 0 | -15K | -52K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15K | -52K |
| Other Financing | -65.35M | 65.35M | 33.32M | 0 | 0 | 0 | 175.63M | 210.07K | 18.78M | 54.66M | 417.96K | 48.72M | 143K | 671K | 0 | 0 | 0 | -89K | -17K | -116K |
| Net Change in Cash | -30.83M | -800K | 20.71M | -2.6M | -11.12M | -67.95M | 47.07M | -94.81M | 88.53M | 36.44M | -24.3M | 99.18M | -16.41M | -18.87M | 26.72M | -52M | -24.43M | 60.34M | -10.98M | -7.98M |
| Free Cash Flow | -33.07M | -45.37M | -38.34M | -42.36M | -39.97M | -42.07M | -13.73M | -27.76M | -23.83M | -31.73M | -13.11M | -17.4M | -20.29M | -25.83M | -20.51M | -16.85M | -23.17M | -24.02M | -20.27M | -18.67M |
| FCF Margin % | -45.64% | -89.03% | -101.33% | -154.13% | -165.05% | -207.7% | -55.91% | -110.14% | -109.08% | -168.97% | -55.71% | -83.44% | -95.98% | -150.24% | -113.34% | -104.66% | -139.56% | -177.09% | -125.34% | -164.48% |
| FCF Growth % | 17.26% | -7.85% | -179.18% | -52.58% | -67.7% | -32.56% | -4.76% | -59.55% | -17.46% | -22.86% | 36.07% | -3.27% | 12.45% | -7.53% | -1.15% | 9.76% | -21.87% | 13.24% | 5.33% | 27.47% |
| FCF per Share | -0.66 | -0.90 | -0.78 | -0.88 | -0.84 | -0.89 | -0.29 | -0.64 | -0.65 | -0.95 | -0.36 | -0.54 | -0.86 | -1.11 | -0.89 | -0.74 | -1.02 | -1.06 | -0.90 | -0.83 |
| FCF Conversion (FCF/Net Income) | 2.30x | 1.92x | 1.45x | 1.27x | 0.80x | 0.96x | 0.36x | 1.17x | 0.71x | 0.98x | 0.50x | 0.79x | 0.84x | 0.85x | 0.71x | 0.65x | 0.87x | 0.85x | 0.71x | 0.61x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |